WASHBURN THEODORE JAMES JR. 1874199 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-02 | 2023-08-01 | 2023-08-01 | 4 | Washburn Theodore James Jr. | PRINCIPAL ACCOUNTING OFFICER | dsp | 1232.0 | 17.88 | 0.22 | 26.26 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 5659.0 | 55.58 (AGIO) |
| 2023-08-02 | 2023-08-01 | 2023-08-01 | 4 | Washburn Theodore James Jr. | PRINCIPAL ACCOUNTING OFFICER | acq | 4150.0 | 60.22 | 0.75 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 6891.0 | 55.58 (AGIO) |
| 2023-08-09 | 2023-08-07 | 2023-08-07 | 4 | Washburn Theodore James Jr. | PRINCIPAL ACCOUNTING OFFICER | dsp | 2918.0 | 51.56 | 0.52 | 25.39 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 2741.0 | 55.74 (AGIO) |
| 2024-02-14 | 2024-02-12 | 2024-02-14 | 4 | Washburn Theodore James Jr. | PRINCIPAL ACCOUNTING OFFICER | dsp | 273.0 | 7.76 | 0.05 | 25.14 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 3245.0 | 55.89 (AGIO) |
| 2024-02-14 | 2024-02-12 | 2024-02-12 | 4 | Washburn Theodore James Jr. | PRINCIPAL ACCOUNTING OFFICER | acq | 777.0 | 22.09 | 0.14 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 3518.0 | 55.89 (AGIO) |
| 2024-02-22 | 2024-02-20 | 2024-02-20 | 4 | Washburn Theodore James Jr. | PRINCIPAL ACCOUNTING OFFICER | dsp | 504.0 | 15.53 | 0.09 | 26.63 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 2741.0 | 56.19 (AGIO) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Washburn Theodore James Jr. | PRINCIPAL ACCOUNTING OFFICER | acq | 3127.0 | 54.69 | 0.56 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 5718.0
|
56.19 (AGIO) |
| 2024-03-05 | 2024-03-01 | 2024-03-05 | 4 | Washburn Theodore James Jr. | PRINCIPAL ACCOUNTING OFFICER | dsp | 1214.0 | 20.19 | 0.22 | 32.57 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 4799.0
|
56.19 (AGIO) |
| 2024-03-07 | 2024-03-05 | 2024-03-05 | 4 | Washburn Theodore James Jr. | PRINCIPAL ACCOUNTING OFFICER | dsp | 1913.0 | 39.86 | 0.34 | 31.75 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 2886.0 | 56.19 (AGIO) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-02 | 2023-08-01 | 2023-08-01 | 4 | Washburn Theodore James Jr. | PRINCIPAL ACCOUNTING OFFICER | dsp | 4150.0 | 100.0 | 0.75 | 0.0 | Direct | Restricted Stock Units | AGIOS PHARMACEUTICALS, INC. | code M | 0.0 | 55.58 (AGIO) |
| 2024-02-14 | 2024-02-12 | 2024-02-12 | 4 | Washburn Theodore James Jr. | PRINCIPAL ACCOUNTING OFFICER | dsp | 777.0 | 100.0 | 0.14 | 0.0 | Direct | Restricted Stock Units | AGIOS PHARMACEUTICALS, INC. | code M | 0.0 | 55.89 (AGIO) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Washburn Theodore James Jr. | PRINCIPAL ACCOUNTING OFFICER | acq | 7350.0 | 100.0 | 1.31 | 0.0 | Direct | Restricted Stock Units | AGIOS PHARMACEUTICALS, INC. | code A | 7350.0 | 56.19 (AGIO) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Washburn Theodore James Jr. | PRINCIPAL ACCOUNTING OFFICER | dsp | 3127.0 | 39.95 | 0.56 | 0.0 | Direct | Restricted Stock Units | AGIOS PHARMACEUTICALS, INC. | code M | 4700.0
|
56.19 (AGIO) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)